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Introduction
While the sympathetic innervation of adult rat sweat glands
is cholinergic, the axons that initially innervate the sweat
gland are noradrenergic (Landis and Keefe, 1983; Leblanc
and Landis, 1986; Stevens and Landis, 1987). Thus, there
is a switch in the neurotransmitter phenotype of these sym-
pathetic neurons. Cross-innervation studies in vivo indicate
that this switch is target-directed. Neurons that normally
innervate sweat glands fail to acquire cholinergic proper-
ties when they are made to innervate the parotid gland, a
target whose sympathetic innervation is ordinarily nora-
drenergic (Schotzinger and Landis, 1990). Furthermore,
normally noradrenergic sympathetic neurons that innervate
hairy skin become cholinergic when they are made to inner-
vate sweat glands (Schotzinger and Landis, 1988). Acqui-
sition of immunoreactivity for vasoactive intestinal peptide
(VIP), a neuropeptide present in mature sweat gland inner-
vation, is also target-dependent (Landis et al., 1988;
Schotzinger and Landis, 1988; Stevens and Landis, 1990
and unpublished observations). Although the evidence for
ta get control of transmitter phenotype is compelling, the
identity of the molecules involved is not known. 
We nd others previously found that extracts of rat foot-
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Sweat glands in rat footpads contain a neuronal differ-
entiation activity that switches the phenotype of sym-
pathetic neurons from noradrenergic to cholinergic
during normal development in vivo. Extracts of devel-
oping and adult sweat glands induce changes in neuro-
transmitter properties in cultured sympathetic neurons
that mimic those observed in vivo. We have character-
ized further the factors present in the extract and com-
pared their properties to those of known cholinergic fac-
tors. When assayed on cultured rat sympathetic
neurons, the major activities in footpad extracts from
postnatal day 21 rat pups that induce choline acetyl-
transferase (ChAT) and vasoactive intestinal peptide
(VIP) and reduce catecholamines and neuropeptide Y
(NPY) are associated with a soluble protein of 22-26103
Mr and a pI of 5.0. These properties are similar to those
of ciliary neurotrophic factor (CNTF). Moreover, the
purified fraction from footpads has ciliary neurotrophic
activity. Antibodies to CNTF that immunoprecipitate all
differentiation activity from sciatic nerve extracts, a rich
source of CNTF, immunoprecipitate 80% of the cholin-
ergic activity in the footpad extracts, 50% of the VIP
and 20% of the NPY activities. Neither CNTF protein
nor CNTF mRNA, however, can be detected in
immunoblot and northern analysis of footpads even
though both CNTF protein and mRNA are evident in
sciatic nerve. CNTF-immunoreactivity is associated with
a sparse plexus of sensory fibers in the footpad but not
with sweat glands or the Schwann cells associated with
the . In addition, in situ hybridization studies with
oligonucleotide probes failed to reveal CNTF mRNA in
sweat glands. Comparison of the sweat gland differen-
tiation activity with the cholinergic differentiation factor
from heart cells (CDF; also known as leukemia
inhibitory factor or LIF) suggests that most of the
holinergic activity in foot pads is biochemically distinct
from CDF/LIF. Further, antibodies that block the
activity of CDF/LIF purified from heart-cell-condi-
ti ned medium do not block the ChAT-inducing activity
present in footpad extracts of postnatal day 8 animals.
A ifferentiation factor isolated from skeletal muscle did
not induce cholinergic properties in sympathetic neuron
cultures and therefore is unlikely to be the cholinergic
diff rentiation factor produced by sweat glands. Taken
together, our data suggest that there are at least two
differentiation molecules present in the extracts and that
the major cholinergic activity obtained from footpads is
related to, but distinct from, CNTF. The second factor
remains to be characterized. In addition, CNTF associ-
ated with sensory fibers may make a minor contribu-
t on to the cholinergic inducing activity present in the
extract. 
Key words: CDF/LIF, CNTF, sympathetic neurons,
neurotransmitter plasticity, neural crest.
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pads contain factor(s) that induce choline acetyltransferase
(ChAT) and VIP, and reduce catecholamine and neuropep-
tide Y (NPY) content in cultured sympathetic neurons (Rao
and Landis, 1990; Rohrer, 1992). This activity was not
detected in extracts of parotid gland or hairy skin, tissues
that receive noradrenergic sympathetic innervation. The
cholinergic differentiation activity is evident in developing
footpads as early as postnatal day 5 (P5) and increases over
a period of two weeks to reach adult levels. Therefore, it
is present at the appropriate time in development to be
responsible for the target-mediated noradrenergic-to-cholin-
ergic switch. 
Several puriÞed proteins elicit the same noradrenergic-
to-cholinergic switch in cultured sympathetic neurons and
are therefore candidates for the differentiation signal in
sweat glands. The cholinergic differentiation factor (CDF),
originally puriÞed from heart-cell-conditioned medium
(Patterson and Chun, 1977; Fukada, 1985), is identical to
leukemia inhibitory factor (LIF; Yamamori et al., 1989).
Recombinant CDF/LIF also inßuences neuropeptide
expression in cultured sympathetic neurons in a manner
very similar to that of the footpad factor (Rao and Landis,
1990; Nawa et al., 1990). Studies using the reverse tran-
scriptase/polymerase chain reaction (RT-PCR) revealed that
CDF/LIF mRNA is selectively localized in postnatal rat
footpads (Yamamori, 1991). Another candidate for the
sweat gland cholinergic factor is ciliary neurotrophic factor
(CNTF; Lin et al., 1989; Stockli et al., 1989). This protein
regulates cholinergic, noradrenergic and neuropeptide prop-
erties in cultured sympathetic neurons in the same fashion
as CDF/LIF (Ernsberger et al., 1989; Saadat et al., 1989;
Rao et al., 1992a). A third cholinergic factor, MANS (mem-
brane associated neurotransmitter stimulating factor), was
partially puriÞed from rat spinal cord (Wong and Kessler,
1987; Adler et al., 1989). MANS appears to be related to
CNTF since it supports the survival of chick ciliary neu-
rons (Rao et al., 1990) and antibodies to CNTF immuno-
precipitate the cholinergic inducing activity of MANS and
detect a band of 24· 103, the relative molecular mass of
CNTF (Carnow et al., 1985; Manthorpe et al., 1986), on
immunoblots of MANS preparations (Rao et al., 1992b).
Finally, a cholinergic differentiation factor, which is bio-
chemically distinct from CDF/LIF and CNTF, has been
purified from skeletal muscle. It enhances the survival of
motor neurons in vitro and in vivo and increases levels of
ChAT in spinal cord cultures (McManaman et al., 1988,
1989, 1990). The ability of the skeletal muscle cholinergic
differentiation factor to induce cholinergic properties in
sympathetic neurons has not been tested. Since CDF/LIF
and CNTF, two of the factors that induce cholinergic func-
tion in sympathetic neurons, affect motor neurons (Geiss
and Weber, 1984; Martinou et al., 1989; 1992; Sendtner et
al., 1990; Arakawa et al., 1990), it seemed plausible that
the skeletal muscle cholinergic factor would also induce
cholinergic function in sympathetic neurons. 
To determine if any of the known cholinergic factors is
present in sweat gland, we further characterized the cholin-
ergic inducing activity from footpad extracts and compared
its properties with CDF/LIF, CNTF and the cholinergic
factor from skeletal muscle. We found that most of the
differentiation activity present in footpads of young rats is
associated with a molecule(s) that is immunoprecipitated by
antibodies that recognize CNTF. We did not, however,
detect either CNTF mRNA or protein in footpads in
immunoblot, in northern blot or in situ hybridization analy-
es, suggesting that the major differentiation factor present
in the extracts and recognized by CNTF antibodies is sim-
ilar, but not identical, to CNTF. The second differentiation
activity is as yet uncharacterized. 
Materials and methods
Cell culture reagents were obtained from Gibco (Grand Island,
NY). 24- and 96-well culture plates were purchased from Corn-
ing (Corning, NY). Affi-gel 10 was obtained from Bio-rad (Rich
mond, CA.). The Centricon filters were purchased from Amicon
(Danvers, MA). [3H]acetyl-CoA was purchased from New Eng-
land Nuclear (Wilmington, DE). T4 polynucleotide kinase and 3¢
end terminal transferase were obtained from (BRL), gamma 32P
from Amersham (Arlington Heights, IL) and 35S-dATP from
NEN. The VIP RIA kit was obtained from INCSTAR (Min-
neapolis, MN) and the NPY RIA kit and rat NPY were obtained
from Peninsula (Belmont, CA). Dispase was purchased from
Boehringer-Mannheim (Indianapolis, IN) and collagenase from
Worthington Biochemicals (Freehold, NJ). Genescreen mem-
branes were obtained from NEN. Vectastain ABC immunoperox-
idase kits were obtained from Vector Laboratories (Burlingame,
CA) and diaminobenzidine from Polysciences (Warrington, PA).
The rabbit antiserum against CGRP and the avidin-Texas red con-
jugates were obtained from Amersham. Other chemicals were pur-
chased from Sigma Chemical Co. (St Louis, MO). Nerve Growth
Factor (NGF) was provided by Dr Ken Neet (Department of Bio-
chemistry, Chicago Medical School). An antiserum that blocks the
activity of CDF/LIF was obtained from R & D Systems (St Paul,
MN) and an antiserum generated against recombinant rat CNTF
was the kind gift of Dr Morrissey at Regeneron Pharmaceuticals
(Tarrytown, NY). Animals were obtained from Zivic Miller
(Zelienople, PA).
Cholinergic factors
Recombinant rat CNTF, produced in E. coli, was obtained from
Regeneron Pharmaceuticals (Tarrytown, NY). Recombinant
human LIF was obtained from AMGEN (Thousand Oaks, CA).
CDF/LIF purified from heart-cell-conditioned medium was pro-
vided by Dr Keiko Fukada (SUNY Downstate, New York, NY;
Fukada et al., 1991). The cholinergic differentiation factor from
skeletal muscle was obtained from Dr J. McManaman (Baylor
College of Medicine, Houston, TX); the HAP7 fraction was used
for all experiments (McManaman et al., 1989). Footpad extracts
were prepared as described previously with the exception that the
whole footpad was used rather than the gland-rich core (Rao and
Landis, 1990). Unless otherwise stated, the DEAE fraction of
extracts from 21-day-old rats was used. Sciatic nerve extracts were
prepared from adult rats as described previously (Rao et al., 1990).
The 0.25 M NaCl eluate of the DEAE column was used for all
the experiments. 
Column chromatography
The soluble fractions of homogenates of footpads of 21-day-old
rats were concentrated(tenfold) with a centriprep microconcen-
trator (Amicon), and the final sample buffer contained 10 mM
phosphate, pH 7.0. 10 mg protein was chromatographed on a
MonoQ column (Pharmacia) using a Whatman HPLC. Fractions
of 0.5 ml were collected while eluting with a linear gradient to
0.1 M NaCl (Fig. 1), and assayed for cholinergic activity on cul-
M. S. Rao, P. H. Patterson and S. C. Landis
733Cholinergic neuronal differentiation factors
tured sympathetic neurons. Active fractions from several runs of
the MonoQ column were pooled, concentrated and chro-
matographed on a MonoP HR 5/5 column (Pharmacia) that had
been equilibrated with 25 mM bis-Tris, pH 7.1. Elution was with
a polybuffer at pH 4.0 containing saturating levels of iminodi-
acetic acid. The flow-through and eluted fractions were adjusted
to neutral pH and stored at - 70°C. Control experiments showed
that the polybuffer did not affect the growth or differentiation of
neuronal cultures. Active fractions (pH 4.9-5.2) were pooled, con-
centrated and chromatographed on a Sepharose 12 column (Phar-
macia) equilibrated in 0.1 M NaCl, 10 mM phosphate, pH 7.0.
Fractions of 0.5 ml were collected and assayed for biological
activity. Protein standards were chromatographed under identical
conditions to determine the approximate sizes of proteins collected
in the various fractions. 
Elution of proteins from SDS-PAGE
The active fractions from the MonoP column were pooled, con-
centratedten foldand subjected to preparative polyacrylamide gel
electrophoresis in sodium dodecyl sulfate (SDS-PAGE). A 15%
acrylamide gel was used in a Biorad apparatus. Regions of the gel
of appropriate relative molecular mass were cut out and loaded
on a Biorad electroeluter. Elution was at 10 mA/tube for 4 hours
in a buffer containing 50 mM ammonium bicarbonate and 0.1%
SDS. Samples were concentrated and SDS precipitated by adding
KCl to a final concentration of 0.1 M, as described by Suzuki and
Terada (1988). Bovine serum albumin (1%; BSA) was added to
the samples, which were then dialyzed on a Centricon apparatus
(10´ 103 Mr size cutoff) to remove excess KCl. Samples were
stored at - 70°C until used.
Cell culture
Cultures of rat sympathetic neurons were prepared as described
by Hawrot and Patterson (1979). Neurons were dissociated enzy-
matically with Dispase (5 mg/ml) and collagenase (1 mg/ml) and
plated in 96-well polylysine-laminin-coated plates. 1000-2000
neurons were plated per well. Neurons were grown in L15-CO2
medium with 7S NGF (100 ng/ml), 10 m M cytosine arabinoside
and 5% adult rat serum, and the medium changed every second
day. The cholinergic factors and column fractions were diluted in
growth medium, sterilized by passage through a 0.2 m m filter and
added to the neurons on the third day of culture. Neurons were
harvested for assay between days 9 and 14 of culture. 
Ciliary ganglia were dissected from embryonic day 8 (E8)
chicks, dissociated and plated in DMEM with 10% fetal calf serum
as described by Varon et al. (1979). 1000-2000 neurons were
plated directly into medium in 96-well culture plates coated
sequentially with polylysine and laminin. The cultures were incu-
bated for 24 hours at 37°C, and fixed with 2% glutaraldehyde as
described by Barbin et al. (1984). The number of surviving neu-
rons was determined by counting phase bright cells with neurites. 
Assays of neurotransmitter properties
The induction of cholinergic function was determined by assay-
ing ChAT activity in homogenates essentially according to the
method of Fonnum (1969). To increase the sensitivity of the assay,
an incubation period of an hour was used. All activity was
inhibitable by 500 m M naphthylvinyl pyridine, a specific inhibitor
of ChAT activity (Smith et al., 1967; White and Wu, 1973).
Tyrosine hydroxylase (TH) content was assayed by
immunoblot. Aliquots of cultured neuron extracts (104 neurons)
were subjected to SDS-PAGE on a 15% minigel and the proteins
transferred to nitrocellulose overnight at 30 mA. The blots were
blocked (5% defatted milk in Tris-buffered saline, pH 7.2) and
then incubated for two hours with a monoclonal antibody that rec-
ognizes tyrosine hydroxylase (TH; 1:1000 dilution, the kind gift
of Dr Ann Acheson, Edmonton, Alberta, Canada; Rohrer et al.,
1986). The blots were stained and developed as described for the
CNTF immunoblots.
Neuropeptide levels were determined by radioimmunoassay.
Neuronal cultures (104 neurons) were rinsed once with PBS and
homogenized in 100m l 2 M acetic acid. After boiling for five
Fig. 1. (A) The major cholinergic inducing activity in footpad
extracts is an acidic protein. Soluble protein extracted from
footpads of 21-day-old rats was chromatographed on a Mono Q
anion exchange column and 0.5 ml fractions were collected,
concentrated and added to sympathetic neuron cultures. 7 days
after the addition of the extracts, neurons were homogenized and
aliquots assayed for ChAT activity. The points represent the
averages of duplicate determinations. The data are expressed as
the fold induction of ChAT activity compared to that present in
cultures grown without added extract. (B) The major cholinergic
inducing activity in footpad extracts has a pI of 5.0. The peak
fraction (12) from the Mono Q column was chromatographed on a
Mono P chromatofocussing column. Fractions were concentrated
and added to sympathetic neuron cultures. 7 days later, the
neurons were homogenized and aliquots were assayed for ChAT
activity. Points are averages of duplicate determinations. The data
are expressed as the fold induction of ChAT activity compared to
that present in cultures grown without added extract. 
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minutes, samples were centrifuged for 1 minute in an Eppendorf
microfuge. Supernatants were dried under vacuum and stored at
- 70°C for subsequent assay. VIP was assayed using primary anti-
bodies previously demonstrated to show minimal crossreactivity
with other peptides. NPY was assayed by the delayed tracer
method as specified in the kit using antibodies, standards and
labeled tracer from Amersham. The standard curve was produced
with rat NPY.
Immunoprecipitation
For the immunoprecipitation experiments in which the biological
activity of the factors was tested, aliquots of CDF/LIF and extracts
of sciatic nerve from adult rats or footpads from 21-day-old ani-
mals sufficient for a cell culture assay were added to buffer (phos-
phate-buffered saline [PBS], pH 7.3 with 2% BSA, 0.2% Triton
X-100, and 0.02% polyethylene glycol 6000). A polyclonal anti-
serum generated against recombinant rat CNTF (obtained from Dr
Donna Morissey, Regeneron Pharmaceuticals) was added to each
vial to a final concentration of 10 m M. After an overnight incu-
bation, the antigen-antibody complex was absorbed to 10 m l of
protein A Sepharose (in the same buffer) for a further two hours
at room temperature. The bound complexes were separated by
centrifugation and the supernatant was diluted into L15-CO2
medium and used for cell culture assays. To ensure that the loss
of activity was due to a specific effect of the antibody, aliquots
of the cholinergic factors were incubated without the antibody and
treated as described above. 
Antibody blocking of CDF/LIF activity
A polyclonal antiserum generated in rabbit against CDF/LIF puri-
fi ed from heart-cell-conditioned medium (the kind gift of Dr Keiko
Fukada, SUNY Downstate, New York, NY; Fukada and Towle,
1992) was used for antibody blocking experiments. Sympathetic
neurons were grown in Optimem defined medium with 100 ng/ml
NGF. On the second day after plating, extract from postnatal day
8 rat pups or CDF/LIF purified from heart cell conditioned
medium (20 ng/ml) were added to the cultures. Antiserum was
added to a final dilution of 1:15 which had been previously deter-
mined to block ChAT induction in response to treatment with puri-
fi ed CDF/LIF. Cultures were fed every fourth day and harvested
on the ninth day after initiating antibody treatment. Samples were
assayed for ChAT activity as described above. Two controls were
performed to examine the specificity of the antiserum. Cultures
were grown in the same dilution of antiserum but in the absence
of CDF/LIF or in the presence of antiserum and sciatic nerve
extract (25 m g/ml). 
CNTF immunoblots
Aliquots of extracts were run on a 15% SDS-PAGE minigel
(Biorad) and the proteins were blotted onto nitrocellulose
(overnight, 30 mA). The blots were blocked (5% defatted milk in
Tris-buffered saline, pH 7.2) and then incubated for two hours
with anti-CNTF antiserum (1:1000 dilution) or with the antibody
preincubated with 10 m M CNTF. The blots were then sequentially
incubated with a biotinylated secondary antibody (1 hour at room
temperature) and avidin conjugated to alkaline phosphatase (0.5
hour). The bound enzyme was detected with NBT (nitroblue tetra-
zolium) and BCIP (bromo-chloro-indoyl phosphate) in 10 mM
bicarbonate buffer, pH 9.5. After color development, the reaction
was stopped by rinsing in distilled water. 
Northern blots
Total RNA was prepared from liver, foot pad and sciatic nerve
using the single step guanidinium-isothiocyanate method (Chom-
czynski and Sacchi, 1987). The RNA was denatured on a 1.5%
aga ose gel containing 12.2 M formaldehyde and blotted onto
Genescreen Plus membranes. Blots were probed with a 45 base
pair an isense oligonucleotide probe for rat CNTF (bases 99-144).
The probe was labeled at the 5¢ end using T4 polynucleotide kinase
nd g mma 32P. Hybridization was performed at 42°C for 48 hours
in buffer consisting of 1 M NaCl, 30% deionized formamide, and
10% dextran sulfate. Blots were sequentially washed at 50oC in
0.1´ SSC and exposed to Kodak XAR-5 film for 3-5 days.
In situ hybridization
The probe used in the northern blot experiments was also used
for in situ hybridization after labeling at the 3¢ end using termi-
nal transferase and 35S-dATP. The sense probe to the same region
was used as a control. The in situ hybridization method was as
described by Siegel (1989). Briefly, fresh-frozen tissue sections
were fixed in 4% formaldehyde for 5 minutes, rinsed three times
in PBS, incubated in acetic anhydride/triethanolamine for 10 min-
utes, rinsed two times briefly in 2´ SSC (0.3 M NaCl, 0.03 M
sodium citrate, pH 7.3) and finally dehydrated through a series of
graded alcohols. The slides were air-dried and processed for
hybridization. After a one hour prehybridization incubation
(4´ SSC, 50% formamide, 500 m g/ml sheared single-stranded
DNA, 250 m g/ml yeast tRNA, 1´ Denharts solution [0.02% Ficoll,
0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin], and
10% dextran sulfate), the blots were rinsed with 2´ SSC and
radioactive probe, diluted in hybridization buffer, was applied at
a concentration of 106 cts/minute/slide. Parafilm coverslips were
placed over the sections and hybridization was carried out in
humid chambers overnight at room temperature. After washing,
the sections were dipped in Kodak NTB-3 emulsion and exposed
for 6 weeks. Sections were developed, fixed and counterstained
with ethidium bromide or cresyl violet.
Immunocytochemistry
The distribution of CNTF immunoreactivity was examined in foot-
pads and in hairy skin. Rats were killed with ether and perfused
through the heart with 4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4, for 10 minutes. The tissue was fixed for an addi-
tional hour by immersion in the paraformaldehyde solution. After
rinsing, the tissue was equilibrated with 30% sucrose in PBS. 15
m m cryostat sections were collected and thaw mounted onto
gelatin-coated slides. The sections were incubated overnight at
room temperature with a primary antiserum generated in rabbit
against a synthetic peptide from CNTF (amino acids 181-200;
Rende et al., 1992; the kind gift of Dr Manthorpe) diluted 1:2000
in dilution buffer (0.5 M NaCl, 0.01 M phosphate buffer, 3%
bovine serum albumin, 0.1% sodium azide and 0.3% Triton X-
100). The sections were rinsed, incubated in biotinylated sec-
ondary antibody for 2 hours, rinsed and then incubated with the
Vectastain avidin-horseradish peroxidase (HRP) complex for 2
hours. After rinsing, the bound antibody was visualized with 3,3¢
diaminobenezidine (0.5 mg/ml) in 0.1 M Tris buffer, pH 7.2, con-
taining 0.02% H2O2. Optimal reaction product developed within
15 seconds to 2 minutes. To control for antiserum specificity, sec-
tions were incubated without primary antibody or with primary
antiserum preabsorbed with 20 m g/ml of recombinant CNTF. In a
second set of experiments, double labeling for CNTF and calci-
tonin gene-related peptide (CGRP), a neuropeptide present in sen-
sory fibers in footpad epidermis (Kruger et al., 1989), was per-
formed. Sections were incubated with the CNTF antiserum, rinsed,
incubated with biotinylated secondary antiserum and then with
avidin conjugated to Texas red. A second series of incubations
was then carried out to detect CGRP. The sections were incubated
with a CGRP antiserum raised in rabbit, rinsed, incubated in goat
anti-rabbit conjugated to fluorescein, rinsed and mounted in
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PBS/glycerin. The sequential use of two rabbit antisera could yield
cross-reactivity between the secondary antisera. Control sections
were incubated with the goat anti-rabbit fluorescein after the
avidin-conjugated Texas red without the second primary antiserum
and no specific fluorescein staining was evident. 
Results
Biochemical characterization of footpad factor
Footpads from postnatal day 21 rats were homogenized and
the extract was applied to a Mono Q anionic exchange
column. This age was selected because previous studies had
shown that footpads from 21-day-old rats had the greatest
amount of cholinergic inducing activity on a per protein
basis (Rao and Landis, 1990). As shown in Fig. 1A, the
cholinergic activity bound to the column and was eluted as
a single peak at 0.25 mM NaCl. This chromatographic pro-
fi le is similar to that of CNTF and the cholinergic factor
from skeletal muscle (Manthorpe et al., 1986; McManaman
et al., 1988, 1989), but is different from that of the basic
protein, CDF/LIF (Fukada, 1985). Similar results were
obtained with extracts from rats 28 days and older (data not
shown). The Mono Q peak fraction was then chro-
matographed on a Mono P column. The cholinergic induc-
ing activity eluted between pH 4.8 and 5.2 (Fig. 1B). The
pH of the peak fraction, 5.0, is similar to the value reported
for CNTF purified from rat sciatic nerve (Manthorpe et al.,
1986). In each case, cholinergic inducing activity was
detected in a single peak. 
To determine the approximate relative molecular masses
of the cholinergic inducing activity, peak fractions from the
Mono P column were chromatographed on a Sepharose 12
column. The activity eluted in a peak between the 16´ 103
Mr and 32´ 103Mr size markers (Fig. 2). This relative mol-
ecular mass is comparable to those of MANS (Wong and
Kessler, 1987), CNTF (Manthorpe et al., 1986) and degly-
cosylated CDF/LIF (Fukada, 1985). The relative molecular
mass of the footpad cholinergic activity was determined
more accurately by SDS-PAGE. Purified material from the
Mono P column was subjected to SDS-PAGE. Slices of the
gel corresponding to 22-26´ 103 and 26-32´ 103 Mr were
removed and the proteins eluted with an electroeluter. As
shown in Fig. 3A, most of the cholinergic activity was
recovered in the 22-26´ 103 Mr fraction. 
The SDS-PAGE fractions were also tested for their
effects on VIP, THand NPY expression. As in the case of
the cholinergic inducing activity, most of the TH- and NPY-
suppressing and VIP-inducing activities were in the 22-
26´ 103 Mr fraction (Fig. 3B-D). 
Comparison of the foot pad cholinergic activity with CNTF
Since the size and pI of the cholinergic differentiation
activity in the footpad extract were very similar to those of
CNTF, we examined the ability of SDS-PAGE-purified
material to support the survival of E8 chick ciliary neurons
in culture, the original assay for CNTF activity (Barbin et
al., 1984; Manthorpe et al., 1986). Fig. 4 shows that the
22-26´103 Mr fraction purified from footpad extract con-
tained a significant level of ciliary neurotrophic activity.
Thus, this fraction contained not only cholinergic and pep-
tidergic differentiating activity for cultured sympathetic
neurons but also ciliary neurotrophic activity. 
To d termine whether the factor(s) present in the foot-
pad extracts was antigenically related to CNTF, an anti-
serum generated against recombinant rat CNTF was used
t  precipitate the cholinergic activity. Since sciatic nerve
contains CNTF (Manthorpe et al., 1986; Lin et al., 1989;
Stockli et al., 1989), extracts of sciatic nerve were used to
optimize immunoprecipitation conditions. The CNTF anti-
serum completely precipitated the cholinergic inducing
activity from sciatic nerve extracts; the ChAT activity
present in cultures treated with sciatic nerve extract from
which the CNTF had been precipitated was equivalent to
the activity present in control cultures (Fig. 5A). Further,
previous studies have shown that the CNTF antiserum com-
pletely immunoprecipitates the peptide-inducing activities
present in sciatic nerve extract (Rao et al., 1992a). While
the CNTF antiserum had no effect on the induction of
ChAT by recombinant CDF/LIF, it precipitated approxi-
mately 80% of the ChAT-inducing activity in the extract
from footpads of 21-day-old rats (Fig. 5A). We also tested
the ability of the CNTF antiserum to immunoprecipitate the
activity in the footpad extract that induces VIP and sup-
presses NPY levels (Fig. 5B,C). Approximately 50% of the
VIP-inducing activity was precipitated, while only 20% of
the NPY activity was removed. Thus, the CNTF antiserum
cross-reacted with a factor(s) present in the footpad extract
and immunoprecipitated the majority of the cholinergic
inducing activity (see also Rohrer, 1992). 
An immunoblot analysis of the extract was performed
using the antiserum generated against recombinant rat
CNTF to determine if the footpad extract contained authen-
Fig. 2. The major cholinergic activity in footpad extracts is a low
relative molecular mass protein. The peak fraction from the Mono
P column was chromatographed on a Sepharose 12 column.
Fractions were concentrated and added to sympathetic neuron
cultures. 7 days after the addition of the extracts, the neurons were
homogenized and aliquots were assayed for ChAT activity. The
points represent the averages of duplicate determinations. The
data ar  expressed as the fold induction of ChAT activity
compared to that present in cultures grown without added extract.
32K and 16K, size markers for 32´ 103 and 16´ 103 Mr. 
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tic CNTF. Previous studies had demonstrated that extracts
of sciatic nerve and footpads contain similar amounts of
cholinergic inducing activity when compared on the basis
of extracted protein (Rao and Landis, 1990). For these
experiments, three different concentrations of footpad
extract and sciatic nerve extract were tested to determine
the amounts of each required to yield equivalent induction
of ChAT activity: 10, 100 and 250 m g of sweat gland extract
caused a 2.3-, 8.1- and 15.3-fold induction and 10, 100 and
250 m g of sciatic nerve extract caused a 3.5-, 12.6- and
23.5-fold change. Equal amounts of cholinergic inducing
activity from extracts of sciatic nerve and footpad were sub-
jected to SDS-PAGE, transferred to nitrocellulose and
probed with the CNTF antiserum. This procedure yielded
a strong signal for recombinant CNTF and a 24´ 103 Mr
band in sciatic nerve (Fig. 6A,B). These bands were absent
when the antiserum was preincubated with 10 m M recom-
binant CNTF (Fig. 6C). No specific bands were evident in
the lanes containing footpad extract which has cholinergic
inducing activity (Fig. 6B, lanes 3,4) or hairy skin extract
(lane 2) which lacks detectable cholinergic inducing activity
(Rao and Landis, 1990). It is important to note that the lanes
containing sciatic nerve and footpad extracts, when assayed
on cultured sympathetic neurons, contained the same
amount of cholinergic inducing activity. Further, we could
still detect a band when ten-fold less sciatic nerve extract
was loaded. These observations suggest that the major
cholinergic activity present in the footpad extracts was not
identi al to CNTF. 
We performed northern blot and in situ hybridization
analy es to ascertain whether CNTF mRNA could be
detect d in footpad. When 30m g of total RNA was probed,
a band of 1.3 kb, the expected size of CNTF mRNA (Stockli
et al., 1989), was detected in sciatic nerve and a faint band
was detected in dorsal root ganglia (Fig. 7). In contrast, no
specific binding was evident in lanes containing RNA from
footp ds or liver. When ten-fold less RNA from sciatic
nerve was loaded than from footpad, CNTF message could
still be detected in sciatic nerve (Fig. 7B). The same
oligon clotide probe was used for in situhybridization
studies of sciatic nerve and sweat gland (Fig. 8). Many
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Fig. 3.Regulation of ChAT, TH, NPY, and VIP by SDS-PAGE
gel fractions. (A) Purified factor from the Mono P column was
subjected to SDS-PAGE, and the fractions corresponding to
relative molecular masses of 22-26´ 103 and 26-32´ 103 were
eluted and added to cultures of dissociated sympathetic neurons. 7
days after the addition of extracts, neurons were homogenized and
aliquots were assayed for ChAT activity. Data are the means of
triplicate determinations (± s.e.m.) and are expressed as the fold
induction of ChAT activity compared to that present in cultures
grown without added extract. (B) Sister cultures treated with SDS-
PAGE eluates as described above were assayed for TH content by
immunoblot. TH content was significantly reduced in cultures
treated with the 22-26´ 103 fraction (band on the right) as
compared to cultures treated with the 26-32´ 103 fraction (band on
the left). (C, D) Sister cultures treated with SDS-PAGE eluates as
described above were assayed for NPY (C) and VIP (D) levels by
radioimmunoassay. Data are the means of triplicate
determinations, ± s.e.m., and are expressed as the fold induction
of neuropeptide immunoreactivity compared to that present in
cultures grown without added extract. 
Fig. 4.The purified cholinergic fraction from footpads also has
ciliary neurotrophic activity. SDS-PAGE gel eluates
corresponding to the 22-26´ 103 Mr and 26-32´ 103 Mr fractions
were added to cultures containing freshly dissociated neurons
from E8 chick ciliary ganglia. 24 hours later, the cultures were
fixed and the number of phase bright cells with neurites was
counted. In A, the results are expressed as the number of surviving
cells/well ± s.e.m. and are means of triplicate samples. Phase
micrographs of the cultures are shown in B (22-26´ 103) and C
(26-32´103).
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Schwann cells in sciatic nerve exhibited a specific hybrid-
ization signal with the antisense probe, while no such signal
was apparent with sense control probe (data not shown).
No signal was evident in sweat gland tissue with the
antisense probe, over either the glands or the Schwann
cells investing the sympathetic innervation of the sweat
glands. 
Since CNTF is known to be present in Schwann cells in
sciatic nerve, and footpads from which the extracts were
made contain branches of this nerve, we used a polyclonal
antiserum generated against a peptide domain of CNTF
(Rende et al., 1992) to localize CNTF-like immunoreactiv-
ity in footpad (Fig. 9). Sections of sciatic nerve, footpad
and hairy skin were incubated with the polyclonal antiserum
and specific staining was localized by the peroxidase-
antiperoxidase method. As expected, strong staining was
observed in a subset of Schwann cells in the sciatic nerve
(data not shown; see Rende et al., 1992; Dobrea et al.,
1992). In addition, CNTF-immunoreactivity was present in
nerve fibers that course through the pad and under the epi-
dermis. This distribution is similar to that of sensory fibers,
including those that contain CGRP (Kruger et al., 1989).
To determine whether the CNTF-immunoreactivity was, in
fact, associated with sensory axons in footpads, double
labeling with antisera against CGRP and CNTF was per-
formed. In all cases, the staining patterns were overlapping.
CNTF-immunoreactivity was also associated with nerve
fi bers associated with the epidermis and in the dermis of
hairy skin (Fig. 9). No CNTF immunoreactivity was
detect ble in the sweat gland secretory coil or in the
Schwann cells associated with the sympathetic innervation
of the sweat glands. Thus, CNTF present in Schwann cells
a sociated with sensory fibers could contribute to the
CNTF-like activity present in extracts from footpads. Since
cholinergic inducing activity is not present in extracts of
h iry skin (Schotzinger and Landis, 1988; Rao and Landis,
1990) which, like footpads, contains nerve bundles with
as ociated CNTF-immunoreactivity, it seems unlikely that
the CNTF present in these nerve bundles is the source of
the m jor fraction of the cholinergic inducing activity.
Comparison of the footpad cholinergic factor with
CDF/LIF
The size and pI values of the major cholinergic inducing
activity in the footpad extract indicated that its biochemi-
cal properties were distinct from glycosylated CDF/LIF. It
 possible, however, that the footpad factor is a post-
translationally modified form of CDF/LIF that has bio-
Fig. 5.Antibodies against CNTF partially
precipitate cholinergic and neuropeptide
differentiation activities from footpad
extracts. (A ) Aliquots of sciatic nerve
extract from adult rats, footpad extract from
21-day-old rats, and CDF/LIF were
incubated with or without polyclonal anti-
CNTF antibodies. After precipitation of the
antibody-antigen complexes with Protein A
Sepharose, the supernatants were added to
cultured sympathetic neurons. After 8 days,
homogenates of the cultured neurons were
assayed for ChAT activity. The results are
expressed as fold-ChAT induction, mean of
triplicate cultures ± s.e.m., compared to
sympathetic neuron cultures grown in
medium without extracts. (B,C) Neuron
were grown (a) without extracts, or with (50
m g/ml) of foot pad extract (crude
homogenate) incubated without (b) or with
(c) the antibody to CNTF. After 8 days,
cultures were assayed for NPY and VIP
induction by radioimmunoassay. Results are
expressed as picograms of peptide per well,
means of triplicate samples ± s.e.m.
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chemical and immunological properties distinct from those
of the protein originally purified from heart-cell-condi-
tioned medium. In addition, the finding that the anti-CNTF
antibodies only partially immunoprecipitated the choliner-
gic inducing activity in footpad extracts suggested that there
is more than one cholinergic factor in the footpad extract.
To examine whether non-glycosylated CDF/LIF co-chro-
matographs with the footpad activity, we added recombi-
nant, non-glycosylated CDF/LIF to the footpad homogenate
and, after an overnight incubation at 4°C, determined
whether CDF/LIF was retained on a DEAE column. As
expected (Fukada, 1985), CDF/LIF was not retained on the
column, even in the presence of footpad extract (Fig. 10).
The footpad factor was, however, retained and no cholin-
ergic inducing activity was detectable in the flow-through
fraction (Fig. 10). Thus, the major footpad activity does not
behave like either glycosylated or non-glycosylated
CDF/LIF.
To determine if any of the cholinergic inducing activity
present in footpad extracts was immunologically related to
CDF/LIF, we employed an antiserum generated against
CDF/LIF purified from medium conditioned by rat heart
cells (Fukada and Towle, 1992). This antiserum blocks the
cholinergic inducing activity of the purified protein on cul-
tured sympathetic neurons (Fig. 11). For these experiments,
extracts were made from postnatal day 8 footpads since RT-
PCR analysis indicated that the highest concentration of
CDF/LIF mRNA is present at this age (Yamamori, 1991)
and extracts from rat pups 5 days and older contain cholin-
ergic inducing activity (Rao and Landis, 1990). As illus-
trated in Fig. 11, the antiserum did not block the effects of
the foo pad extract on ChAT activity; it was not signifi-
cantly different from that of control grown without
CDF/LIF and the blocking antiserum. In addition, the pres-
ence of the antiserum had no effect on the low levels of
ChAT activity normally present, or on the induction of
Ch T by sciatic nerve extract. These observations are con-
sistent with the failure of antibodies raised against the N-
terminal region of CDF/LIF to immunoprecipitate the
cholinergic inducing activity in extracts of footpads from
14-day-old and adult rats (Rao and Landis, 1990; our
unpublished observations).
Comparison of the footpad and skeletal muscle cholinergic
factors
Skeletal muscle from young rats contains a protein that
stimulates the development of ChAT activity in cultures of
E14 rat spinal cord (McManaman et al., 1988). This factor
ha approximately the same relative molecular mass and pI
as the major footpad factor. To assess further the similar-
ity between the factors, we obtained a partially purified
(Hap7) fraction of the skeletal muscle factor and tested its
bility to alter the neurotransmitter properties of cultured
sympathetic neurons. The factor did not alter neuronal sur-
vival. No cholinergic induction was observed at any of the
concentrations tested and no reduction in TH was evident
at the highest concentration tested (Fig. 12). The same frac-
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Fig. 6.CNTF is not detectable in immunoblots of extracts of rat
footpads. 10 ng of recombinant CNTF (A) and various extracts
(B,C) were subjected to SDS-PAGE, transferred to nitrocellulose,
and probed with the anti-CNTF antibodies, with (C) or without
(A,B) preincubation with 10 m g recombinant CNTF. Soluble
protein (DEAE fractions from adult sciatic nerve extract (lane 1;
60 m g), adult hairy skin extract (lane 2; 60 m g), adult footpad
extract (lane 3; 180 m g) or P21 footpad extract (lane 4; 180 m g)
were loaded. The cholinergic inducing activity loaded from sciatic
nerve and footpad extracts is equivalent. As expected, the
antiserum recognized a 24´ 103 band present in the lane containing
authentic CNTF and in the lane containing sciatic nerve extract.
The latter band was not detectable if the antibodies were
preincubated with CNTF. No bands were detected in lanes
containing the other extracts. Arrowheads indicate 92, 30 and
22.5´103 Mr size standards. 
Fig. 7. CNTF mRNA is not detectable in footpad by northern blot
analysis. (A) 30 m g of total RNA from (a) adult sciatic nerve, (b)
footpads, (c) liver and (d) dorsal root ganglia was electrophoresed
and transferred onto nylon membrane. The membrane was then
probed with a labeled oligonucleotide corresponding to bases 99-
144 of rat CNTF. The arrow indicates the strong, 1.3 kb band in
sci tic nerve. A fainter band of similar size is present in the dorsal
root ganglion lane. No specific signal was detected in the lanes
containing either footpad or liver mRNA. Ethidium bromide
staining indicated that the mRNA from all four tissues was intact.
(B) 2.5 m g of total RNA from adult sciatic nerve (lane a) and 25
m g total RNA from footpads (lane b) was probed as described
above. The arrow on the left indicates the 1.3 kb band in sciatic
nerve (lane a) but no band is detectable in footpad (lane b). After
hybridization, the blot was stained with methylene blue to assess
the integrity of the transferred RNA. Arrows on the right indicate
the 28 S and 18 S bands. 
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tion elicited a maximal induction of ChAT (150%) in spinal
cord cultures (Dr J. McManaman, personal communica-
tion). Therefore, it is unlikely that the footpad and skeletal
muscle factor are similar.
Discussion
We have previously shown that extracts of footpads from
both developing and adult rats contain cholinergic differ-
entiation activity when assayed on cultures of neonatal rat
sympathetic neurons (Rao and Landis, 1990). Characteri-
zation of the extracted factor(s) reveal that the major
activity resides in either a single, or several closely related,
soluble macromolecules of pI 5.0 and relative molecular
masses of 22-24´ 103. We have compared the properties of
this major activity to those of three well-characterized
cholinergic factors, a cholinergic differentiation factor from
skeletal muscle, CDF/LIF and CNTF. A fourth cholinergic
factor, MANS, is not a likely candidate for the footpad
factor. Unlike MANS (Adler et al., 1989; Wong and
Kessler, 1987), the footpad activity is easily extracted in
low salt conditions and no detectable activity is associated
with membrane fractions from sweat glands (Rao and
Landis, 1990; our unpublished data). 
The cholinergic factor from skeletal muscle has a pI of
4.8 and a relative molecular mass of 22´ 103 Mr (McMana-
man et al., 1988, 1989, 1990). While this factor had not
been shown to induce cholinergic function in sympathetic
neur ns, CDF/LIF enhances survival of cultured motor neu-
rons and increases their levels of ChAT (Martinou et al.,
1989, 1992) and CNTF supports motorneuron survival in
vitro and in vivo after nerve lesion (Sendtner et al., 1990;
Arak wa et al., 1990). Thus, it seemed possible that the
muscl -derived cholinergic factor would induce cholinergic
function in cultured sympathetic neurons. When we tested
a purified fraction of the skeletal muscle factor for ChAT
induction under the same conditions in which footpad
extract, CDF/LIF and CNTF cause a 10- to 20-fold induc-
tion, the skeletal muscle factor did not alter either ChAT
activity or TH content. These findings make it unlikely that
this factor is responsible for the cholinergic effects of the
Fig. 8.CNTF mRNA is not
detectable in sweat glands by in
situ hybridization. Frozen sections
of sciatic nerve (A) and sweat
gland (C,E) were probed with
either an antisense CNTF
oligonucleotide (A,C) or the
corresponding sense
oligonucleotide (E). Cell nuclei
were visualized with propidium
iodide (B,D,F). Schwann cells in
the sciatic nerve sections
specifically bound the sense CNTF
probe, while no such binding was
detected in sweat glands. ´ 400.
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footpad extract and, further, they suggest that the choliner-
gic factor from skeletal muscle is distinct from CNTF. 
Two soluble proteins, CDF/LIF and CNTF, exert very
similar effects on the expression of neurotransmitter prop-
erties by cultured rat sympathetic neurons; they both
increase ChAT and VIP expression and reduce TH and
NPY expression (Ernsberger et al., 1989; Saadat et al.,
1989; Yamamori et al., 1989; Nawa and Patterson, 1990;
Nawa et al., 1990; Rao et al., 1992a). Each of these effects
is als  elicited by the purified footpad extract. 
CDF/LIF is an attractive candidate for the differentiation
factor in the footpad extract. Its effects on the neurotrans-
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Fig. 9. CNTF
immunoreactivity is absent
from sweat glands but
present in small nerve fibers
in footpad and hairy skin.
Frozen sections of sweat
glands and hairy skin from
adult rats were stained with
an antiserum generated
against a synthetic peptide
sequence from CNTF. In A
and B, immunoreactivity
was localized with avidin-
biotin HRP. The arrows in
A indicate several nerve
fibers that contain CNTF-
immunoreactivity. The
middle and lower portions
of A contain many sweat
gland profiles, two of which
are indicated by asterisks.
In B, a sweat gland
(asterisk) and an adjacent
nerve fiber are shown at
higher magnification. No
specific staining is evident
associated with either the
sweat glands or their
sympathetic innervation. In
C and D, the same section
has been doubly labeled for
CNTF-immunoreactivity
(C) and CGRP (D). The
CNTF immunoreactivity
present in fibers coursing
beneath the epidermis is
associated with intensely
CGRP-immunoreactive
sensory fibers. (E,F) CNTF-
immunoreactive nerve
fibers, indicated by arrows,
are present in hairy skin.
The asterisk indicates
where a hair has been cut.
On either side of the hair
shaft are sebaceous glands
which possess endogenous
peroxidase activity. A
´ 120; B ´ 500, C,D ´ 350, E
´ 150, F ´ 500. 
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mitter phenotype of cultured sympathetic neurons are indis-
tinguishable from those of the purified footpad extract.
Moreover, recent experiments using RT-PCR detected a
selective expression of CDF/LIF mRNA in P8 footpads; in
contrast, CDF/LIF mRNA was not detected in tissues of
postnatal rats that are innervated by noradrenergic sympa-
thetic neurons (Yamamori, 1991). Comparison of the bio-
chemical properties of CDF/LIF with those of the partially
purified footpad factor(s), however, reveals significant dif-
ferences in size and charge. CDF/LIF purified from heart-
cell-conditioned medium is a basic 45´ 103Mr protein while
the major cholinergic inducing activity present in the sweat
gland extract is an acidic protein with a relative molecular
mass in the 22 to 26´ 103 range. In addition, antisera gen-
erated against an N-terminal peptide sequence from
CDF/LIF failed to immunoprecipitate the cholinergic induc-
ing activity from extracts of footpads from adult rats (Rao
and Landis, 1990). The factor in footpad extracts could,
however, represent a post-translationally modified form of
CDF/LIF. Such modifications could account for the differ-
ences in physical properties, as well as the lack of reactiv-
ity with antibodies raised against the N-terminal region of
CDF/LIF. A more stringent test for the presence of
CDF/LIF is the use of an antiserum that directly blocks its
activity. The binding of antibodies in such a serum to
CDF/LIF would be less likely to be affected by post-trans-
lational modifications since the active site of even a mod-
ified CDF/LIF should be available for binding to its neu-
ronal receptor. The blocking antiserum did not inhibit the
cholinergic activity present in extracts of footpads from
postnatal day-8 rat pups, the age at which CDF/LIF mRNA
is most abundant (Yamamori, 1991). Thus, while message
for CDF/LIF is present, we could not detect any CDF/LIF
differentiation activity in the extract. It is possible that
CDF/LIF is present in the footpad extracts at such a low
l vel that a more stringent assay, for example, immuno-
precipit tion after separation of the distinct cholinergic
inducing activities, is required to detect its presence.
Fig. 10.The major footpad cholinergic activity is biochemically
distinct from recombinant CDF/LIF. Extracts from footpads of
adult rats (25 m g/ml) were incubated with or without recombinant
CDF/LIF (25 ng/ml), and applied to a DEAE column. The flow-
through fraction was collected, concentrated and added to cultured
sympathetic neurons. 7 days after the addition of the extracts,
samples were assayed for ChAT activity. Results are expressed as
fold-ChAT induction (± range) as compared to control cultures
grown without extract. The data are means of duplicate cultures;
similar results were obtained in two independent experiments. 
Fig. 11.The cholinergic differentiation activity in sweat gland
extracts is not affected by an antiserum that blocks the function of
CDF/LIF. Sympathetic neuron cultures were grown either in
serum-free medium (control), purified CDF/LIF (20 ng/ml),
sciatic nerve extract (25 m g/ml) or extracts from footpads of
postnatal day 8 rats (25 m g/ml) with (+) or without (- ) CDF/LIF
antiserum (1:15 dilution). Cultures were assayed for ChAT
activity on the ninth day after addition of factors. All samples
were run in triplicate and the data are expressed as the mean fold
induction +s.e.m. Similar results were obtained in three
independent experiments. 
Fig. 12.The cholinergic factor from skeletal muscle does not
i duce ChAT activity or reduce TH content in cultured
sympathetic neurons. Aliquots of the Hap 7 fraction of the skeletal
muscle factor were added to sympathetic neuron cultures. 7 days
after the addition of the extracts, samples were assayed for ChAT
activity. Results are expressed as cts/minute/hour of
incubation/well ± s.e.m. In the inset are shown bands from
immunoblots for TH in control (a) and factor-treated (b, 15ml of
extract) cultures. Neuronal numbers for the control cultures and
increasing factor doses, prior to extraction, were 1952±162;
2077±15; 1993±28; 2033±26, respectively. All samples were run
in duplicate. Similar results were obtained in three experiments. 
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CDF/LIF present in footpads may also be lost during the
extraction. 
The biochemical properties of the major footpad cholin-
ergic activity are strikingly similar to those reported for
CNTF (Manthorpe et al., 1986; Lin et al., 1989; Stockli et
al., 1989). The effects of CNTF and the footpad extract on
the neurotransmitter properties of cultured sympathetic neu-
rons are identical (Saadat et al., 1989; Rao and Landis,
1990; Rao et al., 1992a). Moreover, the footpad extract pos-
sesses ciliary neurotrophic activity, and this property co-
purifies with the cholinergic-inducing activity. These find-
ings, coupled with the immunoprecipitation of much of the
cholinergic and neuropeptide-regulatory activities by anti-
CNTF antibodies, provide evidence for the identity of
CNTF as the major cholinergic factor in the footpad extract. 
Several lines of evidence, however, are inconsistent with
such a conclusion. First, immunoblotting experiments with
polyclonal antibodies against rat CNTF failed to reveal
CNTF immunoreactivity in footpad extracts. Second, north-
ern blot analysis failed to demonstrate detectable CNTF
mRNA in footpads. Third, in immunocytochemical and in
situ hybridization studies, neither sweat glands nor the
Schwann cells associated with their sympathetic innerva-
tion had detectable CNTF immunoreactivity or mRNA. In
each case, comparisons were made with sciatic nerve since
extracts from sciatic nerve and sweat glands contain equiv-
alent amounts of cholinergic inducing activity (Rao and
Landis, 1990) and all the cholinergic inducing activity in
sciatic nerve can be immunoprecipitated with CNTF anti-
serum. Each of the methods yielded positive signals in
analyses of sciatic nerve. This is particularly striking in the
case of the immunoblot experiments in which equivalent
amounts of cholinergic inducing activity from sweat gland
were probed and a signal could be detected in tenfold less
sciatic nerve extract. It is surprising that the CNTF anti-
serum that precipitated cholinergic inducing activity from
both sciatic nerve and sweat gland extracts recognized a
band in the western blot of sciatic nerve extract but not
sweat gland. The immunoprecipitation experiments, how-
ever, were done with native protein while the immunoblot
procedure could have denatured the relevant epitopes.
Immunocytochemical studies demonstrate that at least some
authentic CNTF should also be present in the extract; a
sparse plexus of CNTF-immunoreactive nerve fibers is evi-
dent in the footpads, coursing between the glands and
beneath the epidermis. The contribution that the CNTF
associated with these nerve fibers makes to the cholinergic
inducing activity present in the footpad extracts remains to
be defined. Since, however, a similar distribution of CNTF-
immunoreactive fibers is present in hairy skin, extracts of
which lack cholinergic inducing activity, it seems unlikely
that the nerve fiber-associated CNTF represents the major
source of the differentiation activity present in footpad
extracts. Consistent with this interpretation is the observa-
tion that extracts of footpads of tabby mutant mice that lack
sweat glands (Gruneberg, 1971) but have CNTF-immunore-
active fibers in their footpads contain significantly reduced
levels of cholinergic inducing activity (our unpublished
observations). 
An alternative hypothesis in keeping with our results is
that the major footpad factor is a CNTF-like molecule,
whic  is recognized by some, but not all, of the probes used
in our studies. Further characterization of the immunopre-
cipitated material will clarify this issue. Evidence has
r cently been presented for the existence of such a CNTF
homologue in chick (Eckenstein et al., 1990; Leung et al.,
1992). This molecule, like mammalian CNTF, lacks a signal
p ptid  but in contrast to mammalian CNTF is secreted into
the medium by an unidentified mechanism (Lin et al., 1989;
Stockli et al., 1989; Leung et al., 1992). In addition, the
p esence of an extracellular, soluble CNTF-like molecule
has been reported in optic nerve (Hughes et al., 1988; Lil-
lien et al., 1988) but it is not yet clear if this CNTF-like
molecule is actually released into the medium (Lillien et
al., 1988). 
The CNTF antibodies only partially immunoprecipitated
the neurotransmitter differentiation activities present in the
footpad extract. About 80% of the cholinergic activity from
footp ds, and less of the neuropeptide-regulating activities
was immunoprecipitated. It is unlikely that this is due to
our immunoprecipitation procedures as identical precipita-
tion experiments with sciatic nerve extract precipitated
100% of the cholinergic inducing and peptide inducing
activity (Rao et al., 1992a). Further, independent immuno-
precipitation experiments with a distinct antiserum to CNTF
yi lded a similar result (Rohrer, 1992). These observations
suggest that there are two (or more) distinct cholinergic fac-
tors present in the footpad extract and that the major com-
ponent is CNTF-like. The presence of a second cholinergic
factor, in principle, complicates the quantitative compar-
isons between sciatic nerve and footpad which form the
basis for excluding authentic CNTF as the major differen-
tiation activity. Even when 10-fold more RNA were probed
from sweat glands than from sciatic nerve, however, we did
n t obtain evidence for the presence of CNTF in footpad.
In summary, we have found that most of the differen-
tiation activity present in footpads of young rats is associ-
ated with a molecule(s) that is immunoprecipitated by anti-
bodies hat recognize CNTF. While CNTF message and
protein were easily detected in northern blot, in situ hybrid-
ization and immunoblot analyses of sciatic nerve, we did
no  detect either in footpads. Some activity remains after
immunoprecipitation, suggesting that the extract contains at
le s  two distinct differentiation activities. If two compo-
nents are indeed present in the extract the second, as yet
unch racterized, component, is unlikely to be CDF/LIF as
immunoprecipitation and antibody blocking experiments
hav  failed to detect its presence. Once the differentiation
activities in the extract have been identified, their role in
the directing the changes that occur in neurotransmitter
phenotype in the developing sweat gland innervation in
vivo can be defined.
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